1. Home
  2. TLSA vs EDAP Comparison

TLSA vs EDAP Comparison

Compare TLSA & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • EDAP
  • Stock Information
  • Founded
  • TLSA 2013
  • EDAP 1979
  • Country
  • TLSA United Kingdom
  • EDAP France
  • Employees
  • TLSA N/A
  • EDAP N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TLSA Health Care
  • EDAP Health Care
  • Exchange
  • TLSA Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • TLSA 87.8M
  • EDAP 81.6M
  • IPO Year
  • TLSA 2000
  • EDAP 1997
  • Fundamental
  • Price
  • TLSA $0.64
  • EDAP $2.48
  • Analyst Decision
  • TLSA
  • EDAP Strong Buy
  • Analyst Count
  • TLSA 0
  • EDAP 1
  • Target Price
  • TLSA N/A
  • EDAP $19.00
  • AVG Volume (30 Days)
  • TLSA 1.2M
  • EDAP 42.1K
  • Earning Date
  • TLSA 02-18-2025
  • EDAP 03-26-2025
  • Dividend Yield
  • TLSA N/A
  • EDAP N/A
  • EPS Growth
  • TLSA N/A
  • EDAP N/A
  • EPS
  • TLSA N/A
  • EDAP N/A
  • Revenue
  • TLSA N/A
  • EDAP $70,722,730.00
  • Revenue This Year
  • TLSA N/A
  • EDAP $6.96
  • Revenue Next Year
  • TLSA N/A
  • EDAP $15.53
  • P/E Ratio
  • TLSA N/A
  • EDAP N/A
  • Revenue Growth
  • TLSA N/A
  • EDAP 12.17
  • 52 Week Low
  • TLSA $0.41
  • EDAP $2.00
  • 52 Week High
  • TLSA $1.74
  • EDAP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 38.37
  • EDAP 58.86
  • Support Level
  • TLSA $0.65
  • EDAP $2.15
  • Resistance Level
  • TLSA $0.70
  • EDAP $2.57
  • Average True Range (ATR)
  • TLSA 0.08
  • EDAP 0.14
  • MACD
  • TLSA -0.01
  • EDAP 0.04
  • Stochastic Oscillator
  • TLSA 3.97
  • EDAP 79.55

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: